Bruker BioSpin
Bruker
  • About Us
  • Products
  • Solutions
  • Service & Support
  • News
  • Offices
  • Home
  • Contact
  • Career
  • Events
  • Store
  • Chemistry
  • Pharmaceuticals
    • Quantitative NMR
    • Drug Discovery
      • Compound Verification
      • HTS Assays
      • Dose-Effect
      • Stroke
    • Natural products
  • Proteomics
  • Metabolomics
  • Imaging
  • Food
  • Material Research
  • Process Control
  • Education

Language

  • select language
    • English
    • Français
    • Italiano
    • 简体中文
    • 日本語
    • Русский

Search

Username: Password:
[Register now!]

RSSRSS Feed

News

  • Bruker and Lawrence Berkeley National Laboratory Collaborate on Novel Technology for Structural...
  • Bruker Announces Four Ultra-High Field NMR Orders from the Central European Institute of Technology...
  • CMC-assist™, the First NMR Software Tool Enabling the Seamless, Integrated Routine Workflow from...
  • MR Newsletter 08/2011

Upcoming Events

  • PITTCON 2012
  • 45th ESR Conference of the Royal Society of Chemistry
  • ENC 2012

Dose-Effect

Brain Infarct: Dose-Effect Relation of a New Compound

Courtesy of D. Stiller

Boehringer Ingelheim Pharma, Germany

Dose-Effect
These data were acquired using a BioSpec 47/40

The size of a lesion in the rat brain is reduced after treatment with a new cerebroprotective drug. Lesion appears bright in the T2W-RARE images.

A: Control
B: 3 mg dose
C: 10 mg dose
D: 30 mg dose
 

 
Innovation with Integrity
Bruker AXS | Bruker Daltonics | Bruker Optics
© 2012 Bruker BioSpin | Imprint | Terms of Use | Site Map
 Back to top | Print this page